From Single- to Multi-Target Drugs in Cancer Therapy: When Aspecificity Becomes an Advantage

E-ISSN： 1875-533x|15|5|422-432

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.15, Iss.5, 2008-02, pp. : 422-432

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

How to design multi-target drugs

By Korcsmáros Tamás Szalay Máté S Böde Csaba Kovács István A Csermely Péter

Expert Opinion on Drug Discovery, Vol. 2, Iss. 6, 2007-06 ,pp. : 799-808

Informa Healthcare

Access to resources Recommend Favorite

Multi-Target Drugs for Neglected Diseases

Current Pharmaceutical Design, Vol. 22, Iss. 21, 2016-06 ,pp. : 3135-3163

Bentham Science Publishers

Access to resources Recommend Favorite

Polypharmacology in a Single Drug: Multitarget Drugs

Current Medicinal Chemistry, Vol. 20, Iss. 13, 2013-04 ,pp. : 1639-1645

Bentham Science Publishers

Access to resources Recommend Favorite

Designing drugs with multi-target activity: the next step in the treatment of neurodegenerative disorders

By Geldenhuys Werner J Van der Schyf Cornelis J

Expert Opinion on Drug Discovery, Vol. 8, Iss. 2, 2013-02 ,pp. : 115-129

Informa Healthcare

Access to resources Recommend Favorite

Benzo- and Thienobenzo- Diazepines: Multi-target Drugs for CNS Disorders

Mini Reviews in Medicinal Chemistry, Vol. 15, Iss. 8, 2015-06 ,pp. : 630-647

Bentham Science Publishers

Access to resources Recommend Favorite